DOD Biotech (Thailand) Management Evaluation
| DOD Stock | 2.10 0.12 5.41% |
DOD Biotech employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Inspection of DOD Biotech's management performance can provide insight into the company performance.
| Dusit Chongsutthanamanee Insider Independent Sec |
| Thanin Srisethi Insider Director CEO |
DOD |
DOD Biotech Management Team Effectiveness
The company has return on total asset (ROA) of 0.0281 % which means that it generated a profit of $0.0281 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.04 %, meaning that it generated $0.04 on every $100 dollars invested by stockholders. DOD Biotech's management efficiency ratios could be used to measure how well DOD Biotech manages its routine affairs as well as how well it operates its assets and liabilities.DOD Biotech Workforce Comparison
DOD Biotech Public is one of the top stocks in number of employees category among its peers. The total workforce of Packaged Foods industry is currently estimated at about 128. DOD Biotech holds roughly 6.0 in number of employees claiming about 5% of equities listed under Packaged Foods industry.
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1. DOD Biotech Public Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. DOD Biotech Public Price Series Summation is a cross summation of DOD Biotech price series and its benchmark/peer.
DOD Biotech Notable Stakeholders
A DOD Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DOD Biotech often face trade-offs trying to please all of them. DOD Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DOD Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Dusit Chongsutthanamanee | Independent Sec | Profile | |
| Thanin Srisethi | Director CEO | Profile | |
| Suwarin Konthong | Chief CFO | Profile | |
| Nattawat Phetthai | Accounting Accountant | Profile | |
| Torlarp Chaiyachow | Acting Chairman | Profile | |
| Aekphusit Boonsiriyotthakul | COO Director | Profile |
About DOD Biotech Management Performance
The success or failure of an entity such as DOD Biotech Public often depends on how effective the management is. DOD Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DOD management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DOD management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
DOD Biotech Workforce Analysis
Traditionally, organizations such as DOD Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DOD Biotech within its industry.DOD Biotech Manpower Efficiency
Return on DOD Biotech Manpower
| Revenue Per Employee | 169.2M | |
| Revenue Per Executive | 169.2M | |
| Net Income Per Employee | 8.3M | |
| Net Income Per Executive | 8.3M |
Other Information on Investing in DOD Stock
DOD Biotech financial ratios help investors to determine whether DOD Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOD with respect to the benefits of owning DOD Biotech security.